TY  - JOUR
AU  - Sachpekidis, Christos
AU  - Merz, Maximilian
AU  - Raab, Marc-Steffen
AU  - Bertsch, Uta
AU  - Weru, Vivienn
AU  - Kopp-Schneider, Annette
AU  - Jauch, Anna
AU  - Goldschmidt, Hartmut
AU  - Dimitrakopoulou-Strauss, Antonia
TI  - The prognostic significance of [18F]FDG PET/CT in multiple myeloma according to novel interpretation criteria (IMPeTUs).
JO  - EJNMMI Research
VL  - 11
IS  - 1
SN  - 2191-219X
CY  - Heidelberg
PB  - Springer
M1  - DKFZ-2021-02177
SP  - 100
PY  - 2021
N1  - #EA:E060#LA:E060#
AB  - [18F]FDG PET/CT is the elective imaging modality for treatment monitoring in multiple myeloma (MM). However, MM is a heterogeneous disease from an imaging point of view, raising challenges in interpretation of PET/CT. We herein investigated the prognostic role of the novel Italian Myeloma criteria for PET Use (IMPeTUs) in MM patients undergoing high-dose chemotherapy (HDT) followed by autologous stem cell transplantation (ASCT).Forty-seven patients with newly diagnosed MM underwent [18F]FDG PET/CT before commencement of treatment (baseline PET/CT). Thirty-four of them (72.3
KW  - Interpretation criteria (Other)
KW  - Italian Myeloma criteria for PET Use (IMPeTUs) (Other)
KW  - Multiple myeloma (Other)
KW  - [18F]FDG PET/CT (Other)
LB  - PUB:(DE-HGF)16
C6  - pmid:34628525
DO  - DOI:10.1186/s13550-021-00846-y
UR  - https://inrepo02.dkfz.de/record/176937
ER  -